Localization of Carboxyl Ester Lipase in Human Pituitary Gland and Pituitary Adenomas

被引:10
|
作者
La Rosa, Stefano [1 ]
Vigetti, Davide [2 ]
Placidi, Claudia [3 ]
Finzi, Giovanna [1 ]
Uccella, Silvia [3 ]
Clerici, Moira [2 ]
Bartolini, Barbara [2 ]
Carnevali, Ileana [3 ]
Losa, Marco [4 ]
Capella, Carlo [3 ]
机构
[1] Osped Circolo Varese, Dept Pathol, I-21100 Varese, Italy
[2] Univ Insubria, Dept Biomed Expt & Clin Sci, Varese, Italy
[3] Univ Insubria, Dept Human Morphol, Varese, Italy
[4] Univ Vita Salute, Ist Sci San Raffaele, Dept Neurosurg, Milan, Italy
关键词
carboxyl ester lipase; pituitary; adenoma; localization; SALT-STIMULATED LIPASE; CERAMIDE; CELLS; ACCUMULATION; PURIFICATION; SECRETION; HYDROLASE; PANCREAS; SEQUENCE; REGION;
D O I
10.1369/jhc.2010.956169
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Carboxyl ester lipase (CEL) is an enzyme that hydrolyzes a wide variety of lipid substrates, including ceramides, which are known to show inhibitory regulation of pituitary hormone secretion in experimental models. Because no studies on CEL expression in human pituitary and pituitary adenomas have been reported in the literature, we investigated CEL expression in 10 normal pituitary glands and 86 well-characterized pituitary adenomas [12 FSH/LH cell, 17 alpha-subunit/null cell, 6 TSH cell, 21 ACTH cell, 11 prolactin (PRL) cell, and 19 GH cell adenomas] using IHC, immunoelectron microscopy, Western blotting, and quantitative RT-PCR. In normal adenohypophysis, CEL was localized in GH, ACTH, and TSH cells. In adenomas, it was mainly found in functioning GH, ACTH, and TSH tumors, whereas its expression was poor in the corresponding silent adenomas and was lacking in FSH/LH cell, null cell, and PRL cell adenomas. Ultrastructurally, CEL was localized in secretory granules close to their membranes. This is the first study demonstrating CEL expression in normal human pituitary glands and in functioning GH, ACTH, and TSH adenomas. Considering that CEL hydrolyzes ceramides, inactivating their inhibitory function on pituitary hormone secretion, our findings suggest a possible role of CEL in the regulation of hormone secretion in both normal and adenomatous pituitary cells. (J Histochem Cytochem 58:881-889,2010)
引用
收藏
页码:881 / 889
页数:9
相关论文
共 50 条
  • [41] Homeoproteins and pituitary adenomas.
    Barlier, A
    PellegriniBouiller, I
    Gunz, G
    Jaquet, P
    Enjalbert, A
    ANNALES D ENDOCRINOLOGIE, 1997, 58 (01) : 3 - 10
  • [42] Molecular pathology of pituitary adenomas
    Ricardo V. Lloyd
    Journal of Neuro-Oncology, 2001, 54 : 111 - 119
  • [43] The history of the treatment of pituitary adenomas
    Nicholas F. Maartens
    Endocrine, 2005, 28 (1) : 9 - 26
  • [44] Smears in the diagnosis of pituitary adenomas
    Ng, H
    ACTA CYTOLOGICA, 1998, 42 (03) : 614 - 618
  • [45] Outcome of radiotherapy for pituitary adenomas
    Sebastian, Patricia
    Balakrishnan, Rajesh
    Yadav, Bijesh
    John, Subhashini
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2016, 21 (05) : 466 - 472
  • [46] Diagnosis and management of pituitary adenomas
    Lleva, Ranee R.
    Inzucchi, Silvio E.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (01) : 53 - 60
  • [47] Management of nonfunctioning pituitary adenomas (NFAs): observation
    Wenyu Huang
    Mark E. Molitch
    Pituitary, 2018, 21 : 162 - 167
  • [48] Ghrelin immunoexpression in pituitary adenomas
    Fabio Rotondo
    Michael Cusimano
    Bernd W. Scheithauer
    Angelo Rotondo
    Luis V. Syro
    Kalman Kovacs
    Pituitary, 2011, 14 : 318 - 322
  • [49] Survivin expression in pituitary adenomas
    Wasko, R
    Jankowska, A
    Waligorska-Stachura, J
    Andrusiewicz, M
    Jaskula, M
    Sowinski, J
    NEUROENDOCRINOLOGY LETTERS, 2005, 26 (03) : 209 - 212
  • [50] Molecular pathology of pituitary adenomas
    Lloyd, RV
    JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (02) : 111 - 119